Wall Street Zen upgraded shares of Arteris (NASDAQ:AIP - Free Report) from a sell rating to a hold rating in a research note released on Monday morning.
Several other research analysts have also recently commented on AIP. TD Cowen boosted their price target on shares of Arteris from $12.00 to $15.00 and gave the stock a "buy" rating in a report on Wednesday, August 6th. Rosenblatt Securities reissued a "buy" rating and issued a $14.00 price objective on shares of Arteris in a research report on Wednesday, May 21st. Three investment analysts have rated the stock with a Buy rating, According to data from MarketBeat, the stock presently has a consensus rating of "Buy" and a consensus price target of $15.00.
Check Out Our Latest Analysis on AIP
Arteris Stock Performance
Shares of NASDAQ:AIP traded down $0.42 during midday trading on Monday, hitting $9.87. The company's stock had a trading volume of 726,449 shares, compared to its average volume of 499,181. The business's 50 day simple moving average is $9.49 and its 200 day simple moving average is $8.24. The company has a market cap of $420.96 million, a P/E ratio of -12.04 and a beta of 1.44. Arteris has a 12-month low of $5.46 and a 12-month high of $14.29.
Arteris (NASDAQ:AIP - Get Free Report) last posted its quarterly earnings results on Tuesday, August 5th. The company reported ($0.11) earnings per share for the quarter, hitting the consensus estimate of ($0.11). The firm had revenue of $16.50 million for the quarter, compared to the consensus estimate of $16.35 million. Arteris had a negative net margin of 52.41% and a negative return on equity of 8,546.17%. Arteris has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. On average, sell-side analysts predict that Arteris will post -0.73 earnings per share for the current fiscal year.
Insider Activity at Arteris
In other Arteris news, Director Saiyed Atiq Raza sold 63,118 shares of the firm's stock in a transaction dated Tuesday, August 5th. The shares were sold at an average price of $13.07, for a total transaction of $824,952.26. Following the completion of the transaction, the director directly owned 590,000 shares in the company, valued at approximately $7,711,300. This trade represents a 9.66% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, major shareholder Bayview Legacy, Llc sold 50,000 shares of the firm's stock in a transaction dated Tuesday, August 5th. The shares were sold at an average price of $13.12, for a total transaction of $656,000.00. Following the transaction, the insider owned 9,839,071 shares of the company's stock, valued at $129,088,611.52. This trade represents a 0.51% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 520,616 shares of company stock worth $6,068,463. 29.10% of the stock is owned by company insiders.
Institutional Investors Weigh In On Arteris
A number of hedge funds and other institutional investors have recently modified their holdings of AIP. Northern Trust Corp boosted its position in shares of Arteris by 6.6% in the fourth quarter. Northern Trust Corp now owns 224,443 shares of the company's stock worth $2,287,000 after acquiring an additional 13,838 shares during the last quarter. BNP Paribas Financial Markets acquired a new stake in shares of Arteris in the fourth quarter worth approximately $214,000. Bank of America Corp DE boosted its position in shares of Arteris by 36.9% in the fourth quarter. Bank of America Corp DE now owns 33,619 shares of the company's stock worth $343,000 after acquiring an additional 9,068 shares during the last quarter. Deutsche Bank AG boosted its position in shares of Arteris by 65.7% in the fourth quarter. Deutsche Bank AG now owns 24,145 shares of the company's stock worth $246,000 after acquiring an additional 9,573 shares during the last quarter. Finally, D. E. Shaw & Co. Inc. acquired a new stake in shares of Arteris in the fourth quarter worth approximately $110,000. 64.36% of the stock is currently owned by hedge funds and other institutional investors.
About Arteris
(
Get Free Report)
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
Featured Stories
Before you consider Arteris, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.
While Arteris currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.